CPAP 'staves off tracheal intubation' in COVID-19 acute respiratory failure
The approach, pending peer review, appears to be better than both standard oxygen and high-flow nasal supply
Among adults hospitalised with acute respiratory failure caused by COVID-19, continuous positive airway pressure (CPAP) reduces the likelihood of needing tracheal intubation, compared with standard oxygen therapy, trial results show.
In contrast, high-flow nasal oxygenation (HFNO) does not add a benefit over standard oxygen therapy, researchers have found.
The results of the Recovery-Respiratory Support trial were posted on medRxiv ahead of peer review and simultaneously
